47 Rue Adrienne Bolland
Ncardia innovative hiPSC-based products and services for drug discovery & development
Ncardia originates from the biotech company Pluriomics that was founded in 2011 by Stefan Braam and Herman Spolders, together with the scientific founders Prof. Dr. Mummery and Prof. Dr. Passier.
Their first product was the Pluricyte Cardiomyocyte Kit that was introduced to the cardiac safety market in 2014. At the moment Ncardia is a leading provider in human cardiovascular and neural stem cell technology, disease modeling and cell-based assay products and services for drug discovery. Their people, products, services, industry knowledge and expertise to develop and generate more innovative stem cell based products and services brought Ncardia to this level.
The Board of Directors of Ncardia consists of:
Ncardia is a privately held Belgium-based company with subsidiaries in the Netherlands and the USA. The investor base of the company includes both public and private funds including Vesalius Biocapital, SFPI-FPIM, SambrInvest, InnovationQuarter, S.R.I.W, Sino-German beta Holding Co. Ltd and founders.
Ncardia has attracted a leadership team of international experts in the areas of commercialization, pharma services, finance, stem cell R&D and manufacturing.
The management team consists of: